Cargando…
Novel Imidazopyridine Derivatives Possess Anti-Tumor Effect on Human Castration-Resistant Prostate Cancer Cells
Prostate cancer (PCa) is the second leading cause of cancer-related death afflicting United States males. Most treatments to-date for metastatic PCa include androgen-deprivation therapy and second-generation anti-androgens such as abiraterone acetate and enzalutamide. However, a majority of patients...
Autores principales: | Ingersoll, Matthew A., Lyons, Anastesia S., Muniyan, Sakthivel, D’Cunha, Napoleon, Robinson, Tashika, Hoelting, Kyle, Dwyer, Jennifer G., Bu, Xiu R., Batra, Surinder K., Lin, Ming-Fong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487901/ https://www.ncbi.nlm.nih.gov/pubmed/26121643 http://dx.doi.org/10.1371/journal.pone.0131811 |
Ejemplares similares
-
Editorial: Metastatic Castration Resistant Prostate Cancer: Prognosis and Treatment
por: Muniyan, Sakthivel, et al.
Publicado: (2022) -
Inhibition of hedgehog signaling improves the anti-carcinogenic effects of docetaxel in prostate cancer
por: Mimeault, Murielle, et al.
Publicado: (2015) -
Substituted imidazopyridines as potent inhibitors of HCV replication()
por: Vliegen, Inge, et al.
Publicado: (2009) -
Recent Developments in the Photochemical Synthesis of Functionalized Imidazopyridines
por: Tran, Christine, et al.
Publicado: (2022) -
Human Prostatic Acid Phosphatase: Structure, Function and Regulation
por: Muniyan, Sakthivel, et al.
Publicado: (2013)